Study of Duloxetine in Elderly Patients With Major Depressive Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Depression, Cognition

In brief

A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder

Key facts

Study ID

NCT00062673

Run by

Eli Lilly and Company

People needed

311

Starts

2003-03-01

Expected to finish

2004-07-01

Last updated by the study team

2007-05-21

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• You must be able to visit the doctor's office for clinic visits, tests, and procedures.
• You must have been diagnosed with major depression, and have had at least one other episode in the past.

You may not qualify if…

• You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.
• You have taken a drug within the last 30 days that has not been approved for use by governmental authorities.

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Middleton, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.